Literature DB >> 8391216

Basic fibroblast growth factor has a differential effect on MyoD conversion of cultured aortic smooth muscle cells from newborn and adult rats.

J W van Neck1, J J Medina, C Onnekink, P F van der Ven, H P Bloemers, S M Schwartz.   

Abstract

MyoD is a master regulatory gene for myogenesis that also converts many mesoderm-derived cells into the skeletal muscle phenotype. Rat aortic smooth muscle cells do not contain MyoD homologous mRNA. However, expression of an exogenously supplied MyoD gene in aortic smooth muscle cells cultured from newborn and adult animals converts these cells to elongated myoblasts and myotubes expressing the skeletal muscle genes for titin, nebulin, myosin, and skeletal alpha-actin. The presence of basic fibroblast growth factor during growth and serum starvation completely inhibits MyoD-mediated conversion in cultures of newborn smooth muscle cells. However, in smooth muscle cell cultures derived from adult rats the presence of fibroblast growth factor increases the conversion frequency. The differential response of exogenous MyoD suggests that the two morphological types of aortic smooth muscle cells, one typical for the newborn rat, the other for the adult rat, represent two distinctive states of differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391216      PMCID: PMC1886934     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Expression of a single transfected cDNA converts fibroblasts to myoblasts.

Authors:  R L Davis; H Weintraub; A B Lassar
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

2.  Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells.

Authors:  D Gordon; L G Mohai; S M Schwartz
Journal:  Circ Res       Date:  1986-12       Impact factor: 17.367

3.  Identification and quantification of actin isoforms in vertebrate cells and tissues.

Authors:  C A Otey; M H Kalnoski; J C Bulinski
Journal:  J Cell Biochem       Date:  1987-06       Impact factor: 4.429

Review 4.  Molecular genetics of myosin.

Authors:  C P Emerson; S I Bernstein
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Cloning and characterization of cDNA sequences corresponding to myosin light chains 1, 2, and 3, troponin-C, troponin-T, alpha-tropomyosin, and alpha-actin.

Authors:  L I Garfinkel; M Periasamy; B Nadal-Ginard
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

6.  Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture.

Authors:  O Kocher; G Gabbiani
Journal:  Differentiation       Date:  1986       Impact factor: 3.880

7.  Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells.

Authors:  M W Majesky; E P Benditt; S M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Factor VII related antigen as an endothelial cell marker in benign and malignant diseases.

Authors:  M Sehested; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.

Authors:  D Bader; T Masaki; D A Fischman
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

View more
  2 in total

1.  Differentiated vascular myocytes: are they involved in neointimal formation?

Authors:  B Holifield; T Helgason; S Jemelka; A Taylor; S Navran; J Allen; C Seidel
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

2.  Characterization of cloned aortic smooth muscle cells from young rats.

Authors:  J M Lemire; C W Covin; S White; C M Giachelli; S M Schwartz
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.